TABLE 3.

Use of antiplatelet and oral anticoagulant therapy at 2‐year follow‐up

	Acute MI n = 1,218	Non‐MI n = 1,156	p value
Aspirin	1,059 (86.9)	936 (81.0)	<.001
Dual antiplatelet therapy	156 (12.8)	199 (17.2)	.003
With clopidogrel	54 (4.4)	158 (13.7)	<.001
With ticagrelor or prasugrel	102 (8.4)	41 (3.5)	<.001
Direct oral anticoagulant	57 (4.7)	88 (7.6)	.003
Vitamin K antagonist	76 (6.2)	90 (7.8)	.14

Note: Values are n(%). Data available in 2,374/2,488 (95.4%) patients.

Abbreviation: MI, myocardial infarction.